Literature DB >> 27904697

Inhibitory effect of bufalin on retinoblastoma cells (HXO-RB44) via the independent mitochondrial and death receptor pathway.

Qingfeng Meng1, Yan Zhao2, LiXin An2, Xia Li3, Ping Liu1.   

Abstract

Cinobufacini (Huachansu) is a Chinese medicine prepared from the skin of Bufo bufo gargarizans Cantor (Bufonidae), and has long been used in traditional Chinese medicine. In the present study, the anti-retinoblastoma constituent bufalin obtained from Cinobufacini was investigated. Treatment of human retinoblastoma (HXO-RB44) cells with bufalin induced apoptosis which was accompanied by a decrease in mitochondrial membrane potential, activation of caspase-9, caspase-8 and caspase-3, as well as changes in the expression of cytochrome C. Bufalin induced the cleavage of caspase-3 and apoptosis, and it was inhibited by both Z-LETD-FMK and Z-IETD-FMK treatment. Taken together, these results demonstrate that bufalin-induced apoptosis in human retinoblastoma (HXO-RB44) cells involved both intrinsic and extrinsic pathways.

Entities:  

Keywords:  Apoptosis; bufalin; mitochondrial transmembrane potential; retinoblastoma

Year:  2016        PMID: 27904697      PMCID: PMC5126339     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  19 in total

1.  Nano-copper induces oxidative stress and apoptosis in kidney via both extrinsic and intrinsic pathways.

Authors:  Abhijit Sarkar; Joydeep Das; Prasenjit Manna; Parames C Sil
Journal:  Toxicology       Date:  2011-10-05       Impact factor: 4.221

2.  Na+/K+-ATPase α3 mediates sensitivity of hepatocellular carcinoma cells to bufalin.

Authors:  Huaxing Li; Peng Wang; Yang Gao; Xiaoyan Zhu; Luming Liu; Lorenzo Cohen; Zhiqiang Meng; Peiying Yang
Journal:  Oncol Rep       Date:  2010-12-22       Impact factor: 3.906

Review 3.  Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.

Authors:  Fanghua Qi; Anyuan Li; Yoshinori Inagaki; Norihiro Kokudo; Sumihito Tamura; Munehiro Nakata; Wei Tang
Journal:  Int Immunopharmacol       Date:  2010-12-24       Impact factor: 4.932

4.  Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways.

Authors:  Fanghua Qi; Yoshinori Inagaki; Bo Gao; Xiaoyan Cui; Huanli Xu; Norihiro Kokudo; Anyuan Li; Wei Tang
Journal:  Cancer Sci       Date:  2011-02-28       Impact factor: 6.716

Review 5.  Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions.

Authors:  Avi Ashkenazi
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

6.  Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation.

Authors:  Chuan-Ming Xie; Wood Yee Chan; Sidney Yu; Jun Zhao; Christopher H K Cheng
Journal:  Free Radic Biol Med       Date:  2011-06-29       Impact factor: 7.376

7.  Side population cells from HXO-Rb44 retinoblastoma cell line have cancer-initiating property.

Authors:  Jun-Jun She; Peng-Ge Zhang; Xiang-Ming Che; Xuan Wang; Zi-Ming Wang
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

8.  Emodin azide methyl anthraquinone derivative triggers mitochondrial-dependent cell apoptosis involving in caspase-8-mediated Bid cleavage.

Authors:  Yanyan Yan; Xiaodong Su; Yongju Liang; Jianye Zhang; Chengjun Shi; Yu Lu; Lianquan Gu; Liwu Fu
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

9.  Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.

Authors:  Ching-Han Yu; Shu-Fen Kan; Hsiao-Fung Pu; Eileen Jea Chien; Paulus S Wang
Journal:  Cancer Sci       Date:  2008-11-26       Impact factor: 6.716

10.  Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway.

Authors:  Zhitu Zhu; Hongzhi Sun; Guangyou Ma; Zhenghua Wang; Enze Li; Yangyang Liu; Yunpeng Liu
Journal:  Int J Mol Sci       Date:  2012-02-14       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.